arabinofuranosyluracil has been researched along with Disease Models, Animal in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, S; Jiang, Q; Li, S; Li, X; Liang, Q; Luan, J; Ruan, H; Yang, C; Zhang, F; Zhang, R; Zhou, H | 1 |
| An, R; Lang, J; Liu, Y; Sun, X; Wu, T; Zhang, B | 1 |
| Alauddin, MM; Chan, PC; Chang, WT; Lin, CY; Lin, WJ; Liu, RS; Tseng, YL; Wang, HE; Wu, CY | 1 |
| Chang, WY; Chien, YC; Hwang, JJ; Lin, WT; Tsai, ML; Wang, HE; Yang, FY | 1 |
| Alauddin, MM; Baimbridge, F; Borne, AT; Brammer, D; Decker, WK; Fernandes, MR; Gahremanpour, A; Gelovani, JG; Jackson, J; Jeong, HJ; Kundra, V; Li, C; Marini, FC; Mawlawi, O; Mukhopadhyay, U; Najjar, AM; Pan, T; Paolillo, V; Perin, EC; Quan, X; Rabinovich, B; Rios, JM; Robinson, S; Shpall, E; Silva, GV; Soghomonyan, S; Stafford, J; Steiner, D; Thomas, MW; Tian, M; Uthamanthil, R; Volgin, A; Willerson, JT; Young, D; Zheng, Y | 1 |
| Jamard, C; Martin, P; Rimsky, L; Schorr, O; Seignères, B; Trépo, C; Werle, B; Zoulim, F | 1 |
| Blasberg, R; Burgman, P; Cai, S; Finn, R; Gelovani, J; Li, GC; Ling, CC; O'donoghue, J; Serganova, I; Wen, B; Zanzonico, P | 1 |
| Zoulim, F | 1 |
| Cote, PJ; Gerin, JL; Menne, S; Tennant, BC | 1 |
| Prince, AM | 1 |
| Schinazi, RF; Yao, X | 1 |
| Borrelli, E; Hindelang, C; LeMeur, M; Mathis, C | 1 |
| Fox, JJ; Law, JL; Trousdale, MD; Watanabe, KA; Yarber, FA | 1 |
| Ijichi, K; Machida, H; Takezawa, J | 1 |
| Ashida, N; Ikeda, T; Machida, H | 1 |
| Colly, LP; Edelbroek, PM; Honders, W; vd Hoorn, F; Willemze, R | 1 |
1 review(s) available for arabinofuranosyluracil and Disease Models, Animal
| Article | Year |
|---|---|
Combination of nucleoside analogues in the treatment of chronic hepatitis B virus infection: lesson from experimental models.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Deoxycytidine; Disease Models, Animal; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Nucleosides | 2005 |
15 other study(ies) available for arabinofuranosyluracil and Disease Models, Animal
| Article | Year |
|---|---|
Clevudine attenuates bleomycin-induced early pulmonary fibrosis via regulating M2 macrophage polarization.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Bleomycin; Cell Differentiation; Cytokines; Disease Models, Animal; Humans; Macrophages; Male; Mice; Mice, Inbred C57BL; Pulmonary Fibrosis; RAW 264.7 Cells; Respiratory Mucosa; Th2 Cells | 2021 |
Monitoring bone marrow stem cells with a reporter gene system in experimental middle cerebral artery occlusion rat models.
Topics: Animals; Arabinofuranosyluracil; Autoradiography; Behavior, Animal; Bone Marrow Cells; Disease Models, Animal; Feasibility Studies; Genes, Reporter; Herpesvirus 1, Human; Infarction, Middle Cerebral Artery; Isotope Labeling; Male; Rats; Rats, Sprague-Dawley; Stem Cell Transplantation; Stem Cells; Thymidine Kinase; Tomography, Emission-Computed, Single-Photon | 2013 |
Monitoring tumor response with [18F]FMAU in a sarcoma-bearing mouse model after liposomal vinorelbine treatment.
Topics: Animals; Arabinofuranosyluracil; Biological Transport; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Female; Fluorine Radioisotopes; Humans; Liposomes; Mice; Positron-Emission Tomography; Proliferating Cell Nuclear Antigen; Sarcoma; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Vinblastine; Vinorelbine; Xenograft Model Antitumor Assays | 2013 |
Focused ultrasound enhanced molecular imaging and gene therapy for multifusion reporter gene in glioma-bearing rat model.
Topics: Animals; Arabinofuranosyluracil; Blood-Brain Barrier; Brain Neoplasms; Disease Models, Animal; Genes, Reporter; Genetic Therapy; Glioma; Iodine Radioisotopes; Male; Molecular Imaging; Radiopharmaceuticals; Rats; Rats, Inbred F344; Tomography, Emission-Computed, Single-Photon; Ultrasonography | 2015 |
Imaging long-term fate of intramyocardially implanted mesenchymal stem cells in a porcine myocardial infarction model.
Topics: Animals; Arabinofuranosyluracil; Cell Differentiation; Cell Line; Cell Separation; Cell Survival; Disease Models, Animal; Echocardiography; Endothelial Cells; Feasibility Studies; Genes, Reporter; Herpesvirus 1, Human; Lymph Nodes; Lymphatic Vessels; Lymphography; Magnetic Resonance Imaging; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Myocardial Infarction; Myocardium; Positron-Emission Tomography; Swine; Thymidine Kinase; Time Factors; Tomography, X-Ray Computed | 2011 |
Effects of pyrimidine and purine analog combinations in the duck hepatitis B virus infection model.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Blotting, Southern; Cell Survival; Deoxycytidine; Dioxolanes; Disease Models, Animal; Drug Therapy, Combination; Ducks; Emtricitabine; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Hepatitis B, Chronic; Hepatitis, Viral, Animal; Hepatocytes; Polymerase Chain Reaction; Purine Nucleosides; Reverse Transcriptase Inhibitors; Viral Load; Virus Replication | 2003 |
A preclinical model for noninvasive imaging of hypoxia-induced gene expression; comparison with an exogenous marker of tumor hypoxia.
Topics: Adenocarcinoma; Animals; Arabinofuranosyluracil; Biomarkers, Tumor; Cell Hypoxia; Cell Line, Tumor; Disease Models, Animal; DNA-Binding Proteins; Drug Evaluation, Preclinical; Feasibility Studies; Fluorine Radioisotopes; Gene Expression Profiling; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Iodine Radioisotopes; Misonidazole; Nuclear Proteins; Radionuclide Imaging; Radiopharmaceuticals; Rats; Thymidine Kinase; Transcription Factors; Viral Proteins | 2004 |
Chemoimmunotherapy of chronic hepatitis B virus infection in the woodchuck model overcomes immunologic tolerance and restores T-cell responses to pre-S and S regions of the viral envelope protein.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Carrier State; Combined Modality Therapy; Disease Models, Animal; Epitopes; Female; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B Virus, Woodchuck; Hepatitis B, Chronic; Immune Tolerance; Immunotherapy; Marmota; T-Lymphocytes; Vaccination; Viral Envelope Proteins | 2007 |
Severe toxicity of fialuridine (FIAU)
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Hepatitis; Humans; Marmota; Pan troglodytes | 1996 |
Hydrocephalus induction in mice infected with herpes simplex virus type 2 after antiviral treatment.
Topics: Animals; Arabinofuranosyluracil; Brain; Disease Models, Animal; Female; Herpes Genitalis; Herpesvirus 2, Human; Hydrocephalus; Meningoencephalitis; Mice; Mice, Inbred BALB C | 1995 |
A transgenic mouse model for inducible and reversible dysmyelination.
Topics: Animals; Antigens, Differentiation; Arabinofuranosyluracil; Blotting, Northern; Brain; Demyelinating Diseases; Disease Models, Animal; Female; Glial Fibrillary Acidic Protein; Gliosis; Herpesvirus 1, Human; In Situ Hybridization; Male; Mice; Mice, Transgenic; Myelin Basic Protein; Myelin Sheath; Oligodendroglia; Optic Nerve; Promoter Regions, Genetic; Recombinant Fusion Proteins; RNA, Messenger; Sciatic Nerve; Thymidine Kinase | 2000 |
Evaluation of 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil in a rabbit model of herpetic keratitis.
Topics: Acyclovir; Animals; Antiviral Agents; Arabinofuranosyluracil; Cells, Cultured; Cornea; Disease Models, Animal; Drug Evaluation, Preclinical; Keratitis, Herpetic; Male; Ophthalmic Solutions; Rabbits; Simplexvirus | 1992 |
Efficacy of oral treatment with BV-araU against cutaneous infection with herpes simplex type 1 in shaved mice.
Topics: Acyclovir; Administration, Oral; Animals; Antiviral Agents; Arabinofuranosyluracil; Disease Models, Animal; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Herpes Simplex; Immune Tolerance; Male; Mice; Mice, Inbred BALB C | 1992 |
Comparison of antiviral efficacies of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (brovavir) and acyclovir against herpes simplex virus type 1 infections in mice.
Topics: Acyclovir; Animals; Antiviral Agents; Arabinofuranosyluracil; Disease Models, Animal; Drug Administration Routes; Encephalitis; Herpes Simplex; Humans; Male; Mice; Simplexvirus; Survival Rate | 1990 |
In vivo studies on high-dose 1-beta-D-arabinofuranosylcytosine (HDara-C) and 1-beta-D-arabinofuranosyluracil (ara-U) with respect to pharmacokinetics, cell kinetics, and cytotoxicity in a rat myelocytic leukemia model (BNML).
Topics: Animals; Arabinofuranosyluracil; Cell Cycle; Colony-Forming Units Assay; Cytarabine; Cytidine Deaminase; Disease Models, Animal; Half-Life; Humans; Kinetics; Leukemia, Myeloid, Acute; Nucleoside Deaminases; Rats; Uridine | 1985 |